Skip to main content

Main navigation

  • Our Research
    • Find Diseases We Study
    • Rare Diseases Research Groups & Studies
    • Publications
  • For Patients
    • Patient Organizations
    • Survey on Impacts of COVID-19
    • Resources for Patients and Families
  • For Researchers
    • RDCRN Conference on Clinical Research for Rare Diseases (CCRRD)
      • Resources From Past CCRRD Conferences
    • RDCRN Training Opportunities
    • Other Rare Disease Initiatives
    • NIH Data Sharing
    • Resources for Researchers
  • News
  • COVID-19 Initiatives
  • About Us
facebook twitter linkedin RDCRN Members Login
Home
facebook twitter linkedin RDCRN Members Login
  • Our Research
    • Find Diseases We Study
    • Rare Diseases Research Groups & Studies
    • Publications
  • For Patients
    • Patient Organizations
    • Survey on Impacts of COVID-19
    • Resources for Patients and Families
  • For Researchers
    • RDCRN Conference on Clinical Research for Rare Diseases (CCRRD)
      • Resources From Past CCRRD Conferences
    • RDCRN Training Opportunities
    • Other Rare Disease Initiatives
    • NIH Data Sharing
    • Resources for Researchers
  • News
    • Latest News
    • Spotlight Newsletter
  • COVID-19 Initiatives
    • COVID-19 Resources for Researchers
    • COVID-19 Resources for Patients and Families
    • Survey on Impacts of COVID-19
  • About Us
    • About Us
    • Contact Us

PGM1-CDG

Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC)
Researchers Establish New Consensus Guidelines for Congenital Disorders of Glycosylation
December 07, 2020

Health care providers now have a road map for treating two types of congenital disorders of glycosylation: MPI-CDG and PGM1-CDG. A team of international experts from the Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) published new guidelines for the diagnosis and management of MPI-CDG and PGM1-CDG in the Journal of Inherited Metabolic Disease.

Frontiers in Congenital Disorders of Glycosylation Consortium
FCDGC
MPI-CDG
PGM1-CDG
Subscribe to PGM1-CDG


Your participation makes a world of difference.
Learn How

Stay Up To Date With The Spotlight On Rare Diseases Newsletter

Subscribe

About Spotlight

Tweets by rarediseasesnet

Tags

primary ciliary dyskinesia
EGIDS
BBD
Genetic Disorders of Mucociliary Clearance Consortium
tremor
BVMC
Congenital and Perinatal Infections Rare Diseases Clinical Research Consortium
PCD
Scientist Spotlight
osteogenesis imperfecta

Footer Bottom Links

  • Contact Us
  • Website Policies
    • facebook
    • twitter
    • linkedin

The Rare Diseases Clinical Research Network (RDCRN) is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Office of Rare Diseases Research (ORDR). The RDCRN websites are hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS) under grant number TR002818.